- Home
- RYN vs ACLX Comparison
RYN vs ACLX Comparison
Compare RYN & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYN
- ACLX
- Stock Information
- Founded
- RYN 1926
- ACLX 2015
- Country
- RYN United States
- ACLX United States
- Employees
- RYN N/A
- ACLX N/A
- Industry
- RYN Real Estate Investment Trusts
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- RYN Real Estate
- ACLX Health Care
- Exchange
- RYN Nasdaq
- ACLX Nasdaq
- Market Cap
- RYN 3.5B
- ACLX 4.4B
- IPO Year
- RYN N/A
- ACLX 2022
- Fundamental
- Price
- RYN $22.44
- ACLX $89.53
- Analyst Decision
- RYN Hold
- ACLX Strong Buy
- Analyst Count
- RYN 4
- ACLX 9
- Target Price
- RYN $28.00
- ACLX $117.78
- AVG Volume (30 Days)
- RYN 1.6M
- ACLX 384.8K
- Earning Date
- RYN 11-05-2025
- ACLX 11-05-2025
- Dividend Yield
- RYN 12.91%
- ACLX N/A
- EPS Growth
- RYN 373.92
- ACLX N/A
- EPS
- RYN 5.07
- ACLX N/A
- Revenue
- RYN $1,293,427,000.00
- ACLX $35,898,000.00
- Revenue This Year
- RYN N/A
- ACLX N/A
- Revenue Next Year
- RYN $3.00
- ACLX $220.95
- P/E Ratio
- RYN $4.42
- ACLX N/A
- Revenue Growth
- RYN 47.70
- ACLX N/A
- 52 Week Low
- RYN $21.23
- ACLX $47.86
- 52 Week High
- RYN $32.74
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- RYN 37.02
- ACLX 58.26
- Support Level
- RYN $21.23
- ACLX $84.50
- Resistance Level
- RYN $23.33
- ACLX $90.30
- Average True Range (ATR)
- RYN 0.59
- ACLX 3.88
- MACD
- RYN 0.03
- ACLX -0.24
- Stochastic Oscillator
- RYN 34.67
- ACLX 72.51
About RYN Rayonier Inc. REIT
Rayonier owns and manages over 2 million acres of timberland in the United States. It is one the largest private landowners in North America. Rayonier is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.